Search

The arrival of targeted therapies has presented both a conceptual and a practical challenge in the treatment of patients with advanced non-small cell lung carcinomas (NSCLCs). The relationship of these treatments with specific histologies and predictive biomarkers has made the handling of biopsies the key factor for success. In this study, we highlight the balance between precise histological diagnosis and the practice of conducting multiple predictive assays simultaneously. This can only be achieved where there is a commitment to multidisciplinary working by the tumor board to ensure that a sensible protocol is applied. This proposal for prioritizing samples includes both recent technological advances and the some of the latest discoveries in the molecular classification of NSCLCs. [ABSTRACT FROM AUTHOR]

Background:KRAS mutation testing is required to select patients with metastatic colorectal cancer (CRC) to receive anti-epidermal growth factor receptor antibodies, but the optimal KRAS mutation test method is uncertain.Methods:We conducted a two-site comparison of two commercial KRAS mutation kits - the cobas KRAS Mutation Test and the Qiagen therascreen KRAS Kit - and Sanger sequencing. A panel of 120 CRC specimens was tested with all three methods. The agreement between the cobas test and each of the other methods was assessed. Specimens with discordant results were subjected to quantitative massively parallel pyrosequencing (MPP). DNA blends were tested to determine detection rates at 5% mutant alleles.Results:Reproducibility of the cobas test between sites was 98%. Six mutations were detected by cobas that were not detected by Sanger, and five were confirmed by MPP. The cobas test detected eight mutations which were not detected by the therascreen test, and seven were confirmed by MPP. Detection rates with 5% mutant DNA blends were 100% for the cobas and therascreen tests and 19% for Sanger.Conclusion:The cobas test was reproducible between sites, and detected several mutations that were not detected by the therascreen test or Sanger. Sanger sequencing had poor sensitivity for low levels of mutation. [ABSTRACT FROM AUTHOR]

Two different cultivation systems, aeroponics and hydroponics in greenhouse beds, were compared for the production of potato minitubers. Plants in the aeroponic system showed increased vegetative growth, delayed tuber formation and an extended vegetative cycle of about seven months after transplanting. Therefore in 1999, two production cycles were obtained with the hydroponic system, but only one with the aeroponic system. However, compared with total production in hydroponics, the tuber yield per plant in the aeroponic system was almost 70% higher and tuber number more than 2.5 fold higher. Average tuber weight was reduced by 33% in the aeroponic system. Advantages and possible problems with the aeroponic system for minituber production are discussed. [ABSTRACT FROM AUTHOR]